Thyrocare Technologies Ltd

{"bonusRatio":"2:1"}

{"amount":21}

{"amount":7}

{"amount":7}

{"description":"Thyrocare reported Q4FY26 revenue up 20% and PAT up 128% to ₹48.7 crore; FY26 revenue rose 21%, test volumes surged 29%, and it launched allergy testing and NIPT services.","url":"https://www.cnbctv18.com/market/earnings/thyrocare-posts-strong-q4fy26-pat-jumps-128pc-on-robust-diagnostic-volumes-and-margins-ws-l-19901378.htm","sentiment":"Positive","domain":"CNBCTV18"}

{"description":"Thyrocare Technologies reported a 36.7% rise in net profit to ₹26.1 crore for Q3 2026, driven by diagnostics growth and improved margins. Revenue grew 19.3% YoY to ₹182 crore, with EBITDA surging 46.7%. Shares closed 1.01% higher at ₹458.10 ahead of the announcement.","url":"https://www.cnbctv18.com/market/earnings/thyrocare-q3-profit-up-nearly-37-ebitda-surges-47-diagnostics-drive-margin-expansion-ws-l-19834998.htm","sentiment":"Positive","domain":"CNBCTV18"}

{"description":"Thyrocare Technologies Ltd has announced a 2:1 bonus share issue, with the record date set for November 28, 2025. This marks the company's first bonus share issuance. Additionally, an interim dividend of ₹7 per share has been declared. Shares rose 5.19% to ₹1,568 recently, reflecting a 70% increase in 2025.","url":"https://www.cnbctv18.com/market/thyrocare-technologies-bonus-issue-check-record-date-fixed-for-free-shares-stock-price-reaction-19763167.htm","sentiment":"Positive","domain":"CNBCTV18"}

{"description":"Thyrocare Technologies' stock hit a 52-week high after strong Q2 earnings. The company announced an interim dividend and bonus shares, boosting investor confidence and enhancing the stock's market appeal.","url":"https://www.businesstoday.in/markets/stocks/story/thyrocare-technologies-stock-hits-52-week-high-on-q2-earnings-dividend-bonus-shares-updates-498293-2025-10-15","sentiment":"Positive","domain":"Business Today"}

{"description":"Thyrocare Technologies' stock hit a 52-week high after strong Q2 results, reflecting positive investor sentiment and confidence in the company's financial health, which may impact trading activity and investment decisions.","url":"https://www.thehindubusinessline.com/markets/stock-markets/thyrocare-technologies-stock-hit-52-week-high-in-early-trade-on-strong-q2-results/article70166167.ece","sentiment":"Positive","domain":"The Hindu BusinessLine"}

{"description":"Thyrocare Technologies Ltd's share price surged 17% to a record high of ₹1,474 following an 82% YoY net profit increase in Q2. The rise was bolstered by a bonus issue announcement, indicating strong investor confidence in the company's performance.","url":"https://www.msn.com/en-in/health/other/thyrocare-tech-share-price-pops-17-to-a-new-record-high-as-net-profit-jumps-82-yoy-in-q2/ar-AA1Ouw6y?ocid=BingNewsVerp","sentiment":"Positive","domain":"Mint on MSN"}